GSA Capital Partners’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-30,807
Closed -$196K 1974
2026
Q1
$196K Buy
+30,807
New +$214K 0.01% 1465
2025
Q3
Sell
-54,090
Closed -$280K 1898
2025
Q2
$280K Sell
54,090
-115,953
-68% -$695K 0.02% 1300
2025
Q1
$1.13M Buy
+170,043
New +$1.29M 0.1% 287
2024
Q2
Sell
-69,492
Closed -$429K 1866
2024
Q1
$429K Buy
69,492
+42,932
+162% +$289K 0.03% 984
2023
Q4
$208K Buy
+26,560
New +$171K 0.02% 1307
2023
Q3
Sell
-67,456
Closed -$616K 1728
2023
Q2
$616K Buy
+67,456
New +$560K 0.06% 615

Other funds holding LFST

GSA Capital Partners's LFST Position: Q2 2026 in Review

GSA Capital Partners sold out of Lifestance Health (LFST) in Q2 2026, closing a stake of 30,807 shares — an estimated $196K sold.

GSA Capital Partners first reported a position in LFST in Q2 2023 and held it in 6 quarters. The position peaked at $1.13M in Q1 2025. 287 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • GSA Capital Partners reported no remaining Lifestance Health position as of Q2 2026 after selling out during the quarter.
  • GSA Capital Partners sold 30,807 Lifestance Health shares in Q2 2026, an estimated $196K.
  • GSA Capital Partners first reported a position in Lifestance Health in Q2 2023 and held it in 6 quarters.
  • GSA Capital Partners's Lifestance Health position peaked at $1.13M in Q1 2025.
  • 287 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.